Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.54 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.54 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.48 |
| ▸ | AMY2A | P04746 | 1/20 | 0.44 |
| ▸ | GJA1 | P17302 | 1/20 | 0.44 |
| ▸ | GJB2 | P29033 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23640199 | 1.00 | LGALS8 (0.54) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL25518928 | 1.00 | LGALS8 (0.54) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL11946920 | 1.00 | LGALS8 (0.54) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL19660113 | 1.00 | LGALS8 (0.54) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL18158171 | 1.00 | LGALS8 (0.54) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL22869842 | 0.93 | LGALS8 (0.53) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL19296379 | 0.92 | LGALS8 (0.47) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL23030288 | 0.92 | LGALS8 (0.47) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL22869799 | 0.91 | LGALS8 (0.52) | LGALS8LGALS3LGALS4TYRMEN1 | |
| SCHEMBL22869557 | 0.91 | LGALS8 (0.52) | LGALS8LGALS3LGALS4TYRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192956-A2 | SPHINGOLIPID-LOADED NANOBIOLOGICS FOR IMMUNE REGULATION | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-10-05 | — | — | WO | disclosed |
| US-11155642-B2 | Carboxymethyl cellulose and method of preparation | Core Scientific Creations Ltd. (IL) | 2021-10-26 | — | — | US | disclosed |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
| US-20180133320-A1 | 5-ALA DERIVATIVES AND USE THEREOF | UNIVERSITE DE GENEVE (CH) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180133320-A1 | 5-ALA DERIVATIVES AND USE THEREOF | ALAD, ANXA5, AAAS | LGALS8 1971/4885LGALS3 1055/4885LGALS4 946/4885 |
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | LGALS8 566/4885LGALS3 469/4885LGALS4 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.